Abstract
The opportunistic human pathogen Enterococcus faecium overproduces the low-affinity PBP5. In clinical strains, mutations in PBP5 further reduce its acylation rate by =-lactams. Previous studies have reported that ceftaroline had poor inhibitory activity against =-lactam-resistant E. faecium strains. In this study, we show that ceftaroline exhibits killing activity against our laboratory- derived ampicillin-resistant E. faecium mutant that overproduces a wild-type PBP5 and that ceftaroline inactivates PBP5 much faster than benzylpenicillin and faster than ceftobiprole. Copyright © 2013 White.
Cite
CITATION STYLE
Henry, X., Verlaine, O., Amoroso, A., Coyette, J., Frère, J. M., & Joris, B. (2013). Activity of ceftaroline against Enterococcus faecium PBP5. Antimicrobial Agents and Chemotherapy, 57(12), 6358–6360. https://doi.org/10.1128/AAC.00923-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.